Phase IB-II clinical trial of melatonin oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing chemoradiation.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2017
At a glance
- Drugs Melatonin (Primary)
- Indications Mucositis
- Focus Therapeutic Use
- Acronyms MUCOMEL
- Sponsors Spherium Biomed
- 02 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Mar 2018.
- 02 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Nov 2017.
- 13 Sep 2016 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.